CardioDx Obtains $20,983,348 Series D Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ec9a3583-3815-4d98-b080-cf9b62e828e2 - Date
7/24/2014 - Company Name
CardioDx - Mailing Address
600 Saginaw Drive Redwood City, CA 94063 USA - Company Description
Founded in 2004, CardioDx is a cardiovascular genomic diagnostics company. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. - Website
http://www.cardiodx.com - Transaction Type
Venture Equity - Transaction Amount
$20,983,348 - Transaction Round
Series D - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
